{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T18:45:04Z","timestamp":1777920304382,"version":"3.51.4"},"reference-count":58,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Soc Stud Sci"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:p>This paper compares the development of genetic testing for breast cancer (BRCA testing) in the USA and the UK. It argues that national political cultures played an important role in how these genetic testing technologies were shaped, and that the shapes of these technologies had important implications for the users of these systems. In order to demonstrate the roles of national social and political elements in the development of new genetic testing technologies, I introduce the concept of a technology\u2019s architecture, which is made up of components and the specific ways in which these components are assembled to fulfill particular functions. In the USA, four very different BRCA testing systems initially emerged. However, one biotechnology company, Myriad Genetics, eventually used its legal and economic position to become the sole provider of testing. It offered BRCA testing the way many other laboratory tests were provided in the USA, available to anyone through any physician. The shape of this testing service had important implications for its participants, defining the client as a consumer who could demand access to any of Myriad\u2019s laboratory services, but could not choose among testing systems. In the UK, the government-run National Health Service provided testing through regional genetics clinics, using family history information to assess risks and triage care. Clients in the UK were defined as citizens and patients, who had the right to equal access to the testing system but could not demand any specific services.<\/jats:p>","DOI":"10.1177\/0306312705047172","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T08:15:59Z","timestamp":1109319359000},"page":"5-40","source":"Crossref","is-referenced-by-count":33,"title":["Architectures of Genetic Medicine"],"prefix":"10.1177","volume":"35","author":[{"given":"Shobita","family":"Parthasarathy","sequence":"first","affiliation":[{"name":"Center for Society and Genetics and Department of Public Policy at the\r                        University of California, Los Angeles,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2005,2,1]]},"reference":[{"key":"atypb1","volume-title":"Genetic Susceptibility Testing for Breast and Ovarian Cancer","author":"American Medical Association","year":"1996"},{"key":"atypb2","volume-title":"Statement of the American Society of Clinical Oncology; Genetic Testing for Cancer Susceptibility","author":"American Society of Clinical Oncology","year":"1996"},{"issue":"5","key":"atypb3","first-page":"i","volume":"55","author":"American Society of Human Genetics","year":"1994","journal-title":"American Journal of Human Genetics"},{"key":"atypb4","volume-title":"ASHG Response to Request for Public Comments on Preliminary Final Recommendations on Oversight of Genetic Testing","author":"American Society of Human Genetics","year":"2000"},{"key":"atypb5","volume-title":"Health and Efficiency: A Sociology of Health Economics","author":"Ashmore, Malcolm","year":"1989"},{"key":"atypb6","volume-title":"Of Bicycles, Bakelite, and Bulbs: Towards a Theory of Sociotechnical Change","author":"Bijker, Wiebe","year":"1997"},{"key":"atypb7","volume-title":"The Social Construction of Technological Systems","author":"Bijker, Wiebe E.","year":"1989"},{"key":"atypb8","volume-title":"Policy on Genetic Testing for Breast Cancer Susceptibility","author":"Breast Cancer Action","year":"1996"},{"key":"atypb9","first-page":"36","author":"Brenner, Barbara","year":"1996","journal-title":"Breast Cancer Action Newsletter"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.7.626"},{"key":"atypb11","first-page":"250","volume":"2","author":"Burke, Wylie","year":"1996","journal-title":"Cancer Journal"},{"key":"atypb12","volume-title":"A Policy Framework for Commissioning Cancer Services","author":"Calman, Kenneth","year":"1995"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1177\/030631298028002003"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00162-8"},{"key":"atypb15","volume-title":"\u2018A Pharmaceutical Grammar: Drugs for Life and Direct-to-Consumer Advertising in an Era of Surplus Health\u2019","author":"Dumit, Joseph","year":"2003"},{"key":"atypb16","volume-title":"Backdoor to Eugenics","author":"Duster, Troy","year":"1990"},{"issue":"1","key":"atypb17","first-page":"265","volume":"56","author":"Easton, Douglas F.","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91578-4"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.21.10325"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/3334.001.0001"},{"issue":"19","key":"atypb21","first-page":"5","author":"Hall, Celia","year":"1994","journal-title":"Independent"},{"key":"atypb22","first-page":"4","author":"Hall, Celia","year":"1994","journal-title":"Independent"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1177\/135910539700200104"},{"key":"atypb24","volume-title":"States of Knowledge: The Co-Production of Science and Social Order","author":"Hilgartner, Stephen","year":"2004"},{"key":"atypb25","volume-title":"Counseling in Genetics","author":"Hsia, Edward Y.","year":"1979"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605023341812"},{"key":"atypb27","doi-asserted-by":"crossref","DOI":"10.56021\/9780801828737","volume-title":"Networks of Power: Electrification in Western Society, 1880-1930","author":"Hughes, Thomas P.","year":"1983"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511563706.016"},{"key":"atypb29","volume-title":"Private Science: Biotechnology and the Rise of the Molecular Sciences","author":"Kenney, Martin","year":"1998"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1177\/016224390202700102"},{"key":"atypb31","first-page":"A23","author":"Koenig, Barbara","year":"1996","journal-title":"New York Times"},{"key":"atypb32","volume-title":"Lords of the Fly: Drosophila Genetics and the Experimental Life","author":"Kohler, Robert","year":"1994"},{"key":"atypb33","first-page":"A1","author":"Kolata, Gina","year":"1996","journal-title":"New York Times"},{"key":"atypb34","volume-title":"Science in Action: How to Scientists and Engineers through Society","author":"Latour, Bruno","year":"1987"},{"issue":"4","key":"atypb35","first-page":"8","volume":"14","author":"Lock, Margaret","year":"1998","journal-title":"Anthropology Today"},{"key":"atypb36","volume-title":"Between Bench and Bedside: Science, Healing, and Interleukin-2 in a Cancer Ward","author":"L\u00f6wy, Ilana","year":"1997"},{"key":"atypb37","volume-title":"Familial Breast Cancer: Managing the Risk","author":"Mackay, James","year":"1997"},{"key":"atypb38","volume-title":"Annual Report","author":"Myriad Genetics, Inc.","year":"1995"},{"key":"atypb39","volume-title":"Position Paper: Hereditary Susceptibility Testing for Breast Cancer","author":"National Action Plan on Breast Cancer","year":"1996"},{"key":"atypb40","volume-title":"Genetic Testing for Heritable Breast Cancer Risk","author":"National Breast Cancer Coalition","year":"1996"},{"key":"atypb41","volume-title":"Dangerous Diagnostics: The Social Power of Biological Information","author":"Nelkin, Dorothy","year":"1994"},{"issue":"4","key":"atypb42","first-page":"484","volume":"29","author":"Novas, Carlos","year":"2000","journal-title":"Economy and Society"},{"key":"atypb43","volume-title":"Annual Report","author":"OncorMed Inc.","year":"1995"},{"key":"atypb44","volume-title":"How Users Matter: The Co-Construction of Users and Technology","author":"Parthasarathy, Shobita","year":"2003"},{"key":"atypb45","doi-asserted-by":"publisher","DOI":"10.1177\/030631201031003002"},{"key":"atypb46","volume-title":"Report of Consensus Meeting on the Management of Women with a Family History of Breast Cancer","author":"Research and Development Office of the Anglia and Oxford NHS Executive and Unit for Public Health Genetics","year":"1998"},{"key":"atypb47","author":"Rogers, Lois","year":"1994","journal-title":"Sunday Times"},{"key":"atypb48","volume-title":"Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era","author":"Rothstein, Mark","year":"1997"},{"key":"atypb49","first-page":"244","volume":"2","author":"Schulman, Joseph D.","year":"1996","journal-title":"Cancer Journal"},{"issue":"3","key":"atypb50","first-page":"393","volume":"19","author":"Star, Susan Leigh","year":"1989","journal-title":"Social Studies of Science"},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705153362001"},{"key":"atypb52","volume-title":"Promoting Safe and Effective Genetic Testing in the United States","author":"Task Force on Genetic Testing","year":"1997"},{"key":"atypb53","volume-title":"Draft Guidance: Commissioning Specialized Services","author":"The NHS Executive","year":"1998"},{"key":"atypb54","volume-title":"\u2018Hospital of the University of Pennsylvania Garners Kudos From U.S. News & World Report\u2019s Annual Rankings\u2019","author":"University of Pennsylvania","year":"2002"},{"key":"atypb55","volume-title":"\u2018The Penn School of Medicine Receives Record $327 Million from NIH in FY 2001\u2019. Press Release","author":"University of Pennsylvania","year":"2002"},{"key":"atypb56","volume-title":"National Styles of Regulation: Environmental Policy in Great Britain and the United States","author":"Vogel, David","year":"1986"},{"key":"atypb57","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.2.309"},{"key":"atypb58","volume-title":"Genetics and Cancer Services","author":"Working Group for the Chief Medical Officer","year":"1996"}],"container-title":["Social Studies of Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0306312705047172","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0306312705047172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:26:31Z","timestamp":1777663591000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0306312705047172"}},"subtitle":["Comparing Genetic Testing for Breast Cancer in the USA and the UK"],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1177\/0306312705047172"],"URL":"https:\/\/doi.org\/10.1177\/0306312705047172","relation":{},"ISSN":["0306-3127","1460-3659"],"issn-type":[{"value":"0306-3127","type":"print"},{"value":"1460-3659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}